{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:47:11Z","timestamp":1740138431557,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-022-03258-7","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T08:04:36Z","timestamp":1672128276000},"page":"283-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Looking at the spine in controlled Acromegaly"],"prefix":"10.1007","volume":"79","author":[{"given":"Maria Francesca","family":"Birtolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea G.","family":"Lania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5458-701X","authenticated-orcid":false,"given":"Gherardo","family":"Mazziotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,27]]},"reference":[{"issue":"2","key":"3258_CR1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s11102-021-01198-5","volume":"25","author":"M Fleseriu","year":"2022","unstructured":"M. Fleseriu, A. Barkan, M. Del Pilar Schneider, Y. Darhi, A. de Pierrefeu, A. Ribeiro-Oliveira Jr., S. Petersenn, S. Neggers, S. Melmed, Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States. Pituitary 25(2), 296\u2013307 (2022). https:\/\/doi.org\/10.1007\/s11102-021-01198-5","journal-title":"Pituitary"},{"key":"3258_CR2","doi-asserted-by":"publisher","first-page":"101389","DOI":"10.1016\/j.ghir.2021.101389","volume":"59","author":"MD Whittington","year":"2021","unstructured":"M.D. Whittington, K.A. Munoz, J.D. Whalen, A. Ribeiro-Oliveira, J.D. Campbell, Economic and clinical burden of comorbidities among patients with acromegaly. Growth Horm. IGF Res.: Off. J. Growth Horm. Res. Soc. Int. IGF Res. Soc. 59, 101389 (2021). https:\/\/doi.org\/10.1016\/j.ghir.2021.101389","journal-title":"Growth Horm. IGF Res.: Off. J. Growth Horm. Res. Soc. Int. IGF Res. Soc."},{"issue":"1","key":"3258_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1210\/clinem\/dgaa747","volume":"106","author":"ICM Pelsma","year":"2021","unstructured":"I.C.M. Pelsma, N.R. Biermasz, W.R. van Furth, A.M. Pereira, H.M. Kroon, M. Kloppenburg, K. Claessen, Progression of acromegalic arthropathy in long-term controlled acromegaly patients: 9 years of longitudinal follow-up. J. Clin. Endocrinol. Metab. 106(1), 188\u2013200 (2021). https:\/\/doi.org\/10.1210\/clinem\/dgaa747","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"3258_CR4","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s11102-022-01233-z","volume":"25","author":"ICM Pelsma","year":"2022","unstructured":"I.C.M. Pelsma, H.M. Kroon, V.R. van Trigt, A.M. Pereira, M. Kloppenburg, N.R. Biermasz, K. Claessen, Clinical and radiographic assessment of peripheral joints in controlled acromegaly. Pituitary 25(4), 622\u2013635 (2022). https:\/\/doi.org\/10.1007\/s11102-022-01233-z","journal-title":"Pituitary"},{"issue":"3","key":"3258_CR5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s12020-022-03106-8","volume":"77","author":"B Cangiano","year":"2022","unstructured":"B. Cangiano, E. Giusti, C. Premoli, D. Soranna, G. Vitale, S. Grottoli, V. Cambria, G. Mantovani, R. Mungari, P. Maffei, F. Dassie, A. Giampietro, S. Chiloiro, M.L. Tanda, S. Ippolito, S. Cannav\u00f2, M. Ragonese, A. Zambon, L. Persani, L.M. Fatti, M. Scacchi, Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life. Endocrine 77(3), 510\u2013518 (2022). https:\/\/doi.org\/10.1007\/s12020-022-03106-8","journal-title":"Endocrine"},{"issue":"6","key":"3258_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41574-022-00649-8","volume":"18","author":"G Mazziotti","year":"2022","unstructured":"G. Mazziotti, A.G. Lania, E. Canalis, Skeletal disorders associated with the growth hormone-insulin-like growth factor 1 axis. Nat. Rev. Endocrinol. 18(6), 353\u2013365 (2022). https:\/\/doi.org\/10.1038\/s41574-022-00649-8","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"3258_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00198-003-1531-z","volume":"15","author":"P Vestergaard","year":"2004","unstructured":"P. Vestergaard, L. Mosekilde, Fracture risk is decreased in acromegaly\u2013a potential beneficial effect of growth hormone. Osteoporos. Int.: J. Est. Result Cooperation Eur. Found. Osteoporos. Natl Osteoporos. Found. USA 15(2), 155\u2013159 (2004). https:\/\/doi.org\/10.1007\/s00198-003-1531-z","journal-title":"Osteoporos. Int.: J. Est. Result Cooperation Eur. Found. Osteoporos. Natl Osteoporos. Found. USA"},{"key":"3258_CR8","doi-asserted-by":"publisher","unstructured":"C. Ribeiro de Moura, S. Campos Lopes, A.M. Monteiro (2022) Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01256-6","DOI":"10.1007\/s11102-022-01256-6"},{"issue":"1","key":"3258_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11102-017-0847-1","volume":"21","author":"L Dalle Carbonare","year":"2018","unstructured":"L. Dalle Carbonare, V. Micheletti, E. Cosaro, M.T. Valenti, M. Mottes, G. Francia, M.V. Dav\u00ec, Bone histomorphometry in acromegaly patients with fragility vertebral fractures. Pituitary 21(1), 56\u201364 (2018). https:\/\/doi.org\/10.1007\/s11102-017-0847-1","journal-title":"Pituitary"},{"issue":"12","key":"3258_CR10","doi-asserted-by":"publisher","first-page":"e5088","DOI":"10.1210\/clinem\/dgab259","volume":"106","author":"M Ku\u017ema","year":"2021","unstructured":"M. Ku\u017ema, P. Va\u0148uga, I. S\u00e1gov\u00e1, D. P\u00e1vai, P. Jackuliak, Z. Killinger, N. Binkley, R. Winzenrieth, J. Payer, Vertebral Fractures Occur Despite Control of Acromegaly and Are Predicted by Cortical Volumetric Bone Mineral Density. J. Clin. Endocrinol. Metab. 106(12), e5088\u2013e5096 (2021). https:\/\/doi.org\/10.1210\/clinem\/dgab259","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"3258_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1530\/eje-16-0808","volume":"176","author":"F Malgo","year":"2017","unstructured":"F. Malgo, N.A.T. Hamdy, T.J. Rabelink, H.M. Kroon, K. Claessen, A.M. Pereira, N.R. Biermasz, N.M. Appelman-Dijkstra, Bone material strength index as measured by impact microindentation is altered in patients with acromegaly. Eur. J. Endocrinol. 176(3), 339\u2013347 (2017). https:\/\/doi.org\/10.1530\/eje-16-0808","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"3258_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1530\/eje-16-0340","volume":"175","author":"K Godang","year":"2016","unstructured":"K. Godang, N.C. Olarescu, J. Bollerslev, A. Heck, Treatment of acromegaly increases BMD but reduces trabecular bone score: a longitudinal study. Eur. J. Endocrinol. 175(2), 155\u2013164 (2016). https:\/\/doi.org\/10.1530\/eje-16-0340","journal-title":"Eur. J. Endocrinol."},{"issue":"12","key":"3258_CR13","doi-asserted-by":"publisher","first-page":"e10240","DOI":"10.1002\/jbm4.10240","volume":"3","author":"K Godang","year":"2019","unstructured":"K. Godang, T. Lekva, K.R. Normann, N.C. Olarescu, K.A.B. \u00d8ystese, A. Kolnes, T. Ueland, J. Bollerslev, A. Heck, Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study. JBMR 3(12), e10240 (2019). https:\/\/doi.org\/10.1002\/jbm4.10240","journal-title":"JBMR"},{"key":"3258_CR14","doi-asserted-by":"publisher","first-page":"738895","DOI":"10.3389\/fendo.2021.738895","volume":"12","author":"L Duan","year":"2021","unstructured":"L. Duan, S. Yang, L.J. Wang, Y. Zhang, R. Li, H. Yang, Y. Zhao, H. Du, X. Zhai, F. Gong, H. Pan, H. Zhu, W. Xia, The Negative Impacts of Acromegaly on Bone Microstructure Not Fully Reversible. Front. Endocrinol. 12, 738895 (2021). https:\/\/doi.org\/10.3389\/fendo.2021.738895","journal-title":"Front. Endocrinol."},{"issue":"4","key":"3258_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1530\/eje-20-0415","volume":"183","author":"ICM Pelsma","year":"2020","unstructured":"I.C.M. Pelsma, N.R. Biermasz, A.M. Pereira, W.R. van Furth, N.M. Appelman-Dijkstra, M. Kloppenburg, H.M. Kroon, K. Claessen, Progression of vertebral fractures in long-term controlled acromegaly: a 9-year follow-up study. Eur. J. Endocrinol. 183(4), 427\u2013437 (2020). https:\/\/doi.org\/10.1530\/eje-20-0415","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"3258_CR16","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1210\/jc.2013-1460","volume":"98","author":"G Mazziotti","year":"2013","unstructured":"G. Mazziotti, A. Bianchi, T. Porcelli, M. Mormando, F. Maffezzoni, A. Cristiano, A. Giampietro, L. De Marinis, A. Giustina, Vertebral fractures in patients with acromegaly: a 3-year prospective study. J. Clin. Endocrinol. Metab. 98(8), 3402\u20133410 (2013). https:\/\/doi.org\/10.1210\/jc.2013-1460","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"3258_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1530\/erc-17-0523","volume":"25","author":"MT Valenti","year":"2018","unstructured":"M.T. Valenti, M. Mottes, S. Cheri, M. Deiana, V. Micheletti, E. Cosaro, M.V. Dav\u00ec, G. Francia, L. Dalle Carbonare, Runx2 overexpression compromises bone quality in acromegalic patients. Endocr.-Relat. Cancer 25(3), 269\u2013277 (2018). https:\/\/doi.org\/10.1530\/erc-17-0523","journal-title":"Endocr.-Relat. Cancer"},{"issue":"1","key":"3258_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1530\/ec-18-0482","volume":"8","author":"E Valassi","year":"2019","unstructured":"E. Valassi, N. Garc\u00eda-Giralt, J. Malouf, I. Crespo, J. Llauger, A. D\u00edez-P\u00e9rez, S.M. Webb, Circulating miR-103a-3p and miR-660-5p are associated with bone parameters in patients with controlled acromegaly. Endocr. Connect. 8(1), 39\u201349 (2019). https:\/\/doi.org\/10.1530\/ec-18-0482","journal-title":"Endocr. Connect."},{"issue":"1","key":"3258_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12020-021-02850-7","volume":"75","author":"K Claessen","year":"2022","unstructured":"K. Claessen, I.C.M. Pelsma, H.M. Kroon, A.H. van Lierop, A.M. Pereira, N.R. Biermasz, N.M. Appelman-Dijkstra, Low sclerostin levels after long-term remission of acromegaly. Endocrine 75(1), 228\u2013238 (2022). https:\/\/doi.org\/10.1007\/s12020-021-02850-7","journal-title":"Endocrine"},{"issue":"5","key":"3258_CR20","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s40618-022-01740-7","volume":"45","author":"E Vitali","year":"2022","unstructured":"E. Vitali, E. Palagano, M.L. Schiavone, G. Mantovani, C. Sobacchi, G. Mazziotti, A. Lania, Direct effects of octreotide on osteoblast cell proliferation and function. J. Endocrinol. Investig. 45(5), 1045\u20131057 (2022). https:\/\/doi.org\/10.1007\/s40618-022-01740-7","journal-title":"J. Endocrinol. Investig."},{"issue":"3","key":"3258_CR21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s12020-021-02751-9","volume":"73","author":"MM Uygur","year":"2021","unstructured":"M.M. Uygur, D.D. Yaz\u0131c\u0131, O. Bu\u011fdayc\u0131, D.G. Yavuz, Prevalence of vertebral fractures and serum sclerostin levels in acromegaly. Endocrine 73(3), 667\u2013673 (2021). https:\/\/doi.org\/10.1007\/s12020-021-02751-9","journal-title":"Endocrine"},{"key":"3258_CR22","doi-asserted-by":"publisher","unstructured":"S. Chiloiro, A. Giampietro, S. Frara, C. Bima, F. Donfrancesco, C.M. Fleseriu, A. Pontecorvi, A. Giustina, M. Fleseriu, L. De Marinis, A. Bianchi, Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. J. Clin. Endocrinol. Metab. 105 (3) (2020). https:\/\/doi.org\/10.1210\/clinem\/dgz054","DOI":"10.1210\/clinem\/dgz054"},{"issue":"4","key":"3258_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1530\/eje-17-0772","volume":"178","author":"Z Belaya","year":"2018","unstructured":"Z. Belaya, T. Grebennikova, G. Melnichenko, A. Nikitin, A. Solodovnikov, O. Brovkina, A. Grigoriev, L. Rozhinskaya, A. Lutsenko, I. Dedov, Effects of active acromegaly on bone mRNA and microRNA expression patterns. Eur. J. Endocrinol. 178(4), 353\u2013364 (2018). https:\/\/doi.org\/10.1530\/eje-17-0772","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"3258_CR24","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1159\/000511811","volume":"111","author":"M Cellini","year":"2021","unstructured":"M. Cellini, E. Biamonte, M. Mazza, N. Trenti, P. Ragucci, D. Milani, E. Ferrante, Z. Rossini, E. Lavezzi, E. Sala, G. Mantovani, M. Arosio, M. Fornari, L. Balzarini, A.G. Lania, G. Mazziotti, Vertebral Fractures Associated with Spinal Sagittal Imbalance and Quality of Life in Acromegaly: A Radiographic Study with EOS 2D\/3D Technology. Neuroendocrinology 111(8), 775\u2013785 (2021). https:\/\/doi.org\/10.1159\/000511811","journal-title":"Neuroendocrinology"},{"issue":"2","key":"3258_CR25","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1530\/eje-19-0184","volume":"181","author":"G Mazziotti","year":"2019","unstructured":"G. Mazziotti, A.G.A. Lania, E. Canalis, Management of endocrine disease: Bone disorders associated with acromegaly: mechanisms and treatment. Eur. J. Endocrinol. 181(2), R45\u2013r56 (2019). https:\/\/doi.org\/10.1530\/eje-19-0184","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"3258_CR26","doi-asserted-by":"publisher","first-page":"e2843","DOI":"10.1210\/clinem\/dgac183","volume":"107","author":"S Frara","year":"2022","unstructured":"S. Frara, M. Melin Uygur, L. di Filippo, M. Doga, M. Losa, S. Santoro, P. Mortini, A. Giustina, High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly. J. Clin. Endocrinol. Metab. 107(7), e2843\u2013e2850 (2022). https:\/\/doi.org\/10.1210\/clinem\/dgac183","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3258_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11832-016-0713-0","volume":"10","author":"E Melhem","year":"2016","unstructured":"E. Melhem, A. Assi, R. El Rachkidi, I. Ghanem, EOS(\u00ae) biplanar X-ray imaging: concept, developments, benefits, and limitations. J. Children\u2019s Orthop. 10(1), 1\u201314 (2016). https:\/\/doi.org\/10.1007\/s11832-016-0713-0","journal-title":"J. Children\u2019s Orthop."},{"issue":"6","key":"3258_CR28","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11102-019-00991-7","volume":"22","author":"B de Azevedo Oliveira","year":"2019","unstructured":"B. de Azevedo Oliveira, B. Araujo, T.M. Dos Santos, B.R. Ongaratti, C. Rech, N.P. Ferreira, J.F.S. Pereira-Lima, M. da Costa Oliveira, The acromegalic spine: fractures, deformities and spinopelvic balance. Pituitary 22(6), 601\u2013606 (2019). https:\/\/doi.org\/10.1007\/s11102-019-00991-7","journal-title":"Pituitary"},{"issue":"2","key":"3258_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/jbmr.3595","volume":"34","author":"RL Prince","year":"2019","unstructured":"R.L. Prince, J.R. Lewis, W.H. Lim, G. Wong, K.E. Wilson, B.C. Khoo, K. Zhu, D.P. Kiel, J.T. Schousboe, Adding Lateral Spine Imaging for Vertebral Fractures to Densitometric Screening: Improving Ascertainment of Patients at High Risk of Incident Osteoporotic Fractures. J. Bone Miner. Res.: Off. J. Am. Soc. Bone Miner. Res. 34(2), 282\u2013289 (2019). https:\/\/doi.org\/10.1002\/jbmr.3595","journal-title":"J. Bone Miner. Res.: Off. J. Am. Soc. Bone Miner. Res."},{"issue":"12","key":"3258_CR30","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1210\/jc.2013-2695","volume":"98","author":"KM Claessen","year":"2013","unstructured":"K.M. Claessen, H.M. Kroon, A.M. Pereira, N.M. Appelman-Dijkstra, M.J. Verstegen, M. Kloppenburg, N.A. Hamdy, N.R. Biermasz, Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study. J. Clin. Endocrinol. Metab. 98(12), 4808\u20134815 (2013). https:\/\/doi.org\/10.1210\/jc.2013-2695","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3258_CR31","doi-asserted-by":"publisher","unstructured":"G. Mazziotti, C. Battista, F. Maffezzoni, S. Chiloiro, E. Ferrante, N. Prencipe, L. Grasso, F. Gatto, R. Olivetti, M. Arosio, M. Barale, A. Bianchi, M. Cellini, I. Chiodini, L. De Marinis, G. Del Sindaco, C. Di Somma, A. Ferlin, E. Ghigo, A. Giampietro, S. Grottoli, E. Lavezzi, G. Mantovani, E. Morenghi, R. Pivonello, T. Porcelli, M. Procopio, F. Pugliese, A. Scillitani, A.G. Lania, Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study. J. Clin. Endocrinol. Metab. 105 (9) (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa363","DOI":"10.1210\/clinem\/dgaa363"},{"issue":"5","key":"3258_CR32","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s11102-019-00966-8","volume":"22","author":"LM Fatti","year":"2019","unstructured":"L.M. Fatti, B. Cangiano, G. Vitale, L. Persani, G. Mantovani, E. Sala, M. Arosio, P. Maffei, F. Dassie, M. Mormando, A. Giampietro, L. Tanda, E.R. Masiello, E. Nazzari, D. Ferone, S. Corbetta, E. Passeri, F. Guaraldi, S. Grottoli, S. Cannav\u00f2, M.L.T. Torre, D. Soranna, A. Zambon, F. Cavagnini, M. Scacchi, Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity. Pituitary 22(5), 552\u2013560 (2019). https:\/\/doi.org\/10.1007\/s11102-019-00966-8","journal-title":"Pituitary"},{"issue":"2","key":"3258_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11102-021-01190-z","volume":"25","author":"VR van Trigt","year":"2022","unstructured":"V.R. van Trigt, I.C.M. Pelsma, H.M. Kroon, A.M. Pereira, C. van der Meulen, M. Kloppenburg, N.R. Biermasz, K. Claessen, Low prevalence of neuropathic-like pain symptoms in long-term controlled acromegaly. Pituitary 25(2), 229\u2013237 (2022). https:\/\/doi.org\/10.1007\/s11102-021-01190-z","journal-title":"Pituitary"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03258-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03258-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03258-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T03:52:19Z","timestamp":1675309939000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03258-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,27]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["3258"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03258-7","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2022,12,27]]},"assertion":[{"value":"1 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"G.M. received: consultant fees from Eli Lilly, Ipsen and Novartis; lecture fees from Abiogen and Amgen. A.G. Lania received grants from Pfizer and consultant fees from Ipsen. F.B. and S.A. declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}